ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2011

The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers.

Danny Vesprini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.